BERLIN: Pfizer/BioNTech’s coronavirus vaccine offers more protection than earlier thought with effectiveness in preventing symptomatic disease reaching 97 percent, according to real-world evidence published Thursday by the pharmaceutical companies.
© New Straits Times Press (M) Bhd
